ࡱ >
\ p None B a = c @ = Z ?N*8 X" 1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial General ` Table_2 ' U DBC1* CDKN2B*" Original Set Illumina Array" Validation Set MSP Analysis N Methylated Favorable Group t(15;17) 9 (100%) 19 16 (84%) 5 (55.5%) 7 3 (42%) inv(16) 11 (82%) (56%) 4 (36.4%) 0 - t(8;21) 10 12 8 (66%) (70%) 2 Intermediate Group Normal Karyotype 41 21 (51.2%) 111 54 (49%) 15 (36.6%) 99 42 Trisomy 8 6 (86%) (50%) (28.6%) 1 (33%) Other Intermediate 13 (69%) (52%) (31%) (30%) Adverse Group Complex Karyotype 14 (7%)** (21.4%) (29%) MLL (100%)*** (0%) (14%)
Other Adverse (25%) Other 35 18 Total 116 71 (61%) 244 128 43 (37%) 151 61 (40%)
d MbP?_ %
* + &P &F